This Article Full Text Full Text (PDF) All Versions of this Article: 34/4/901    most recent 01.STR.0000064322.47667.49v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boriani, G. Articles by Branzi, A. Search for Related Content PubMed PubMed Citation Articles by Boriani, G. Articles by Branzi, A. Related Collections Congestive Pacemaker Arrhythmias, clinical electrophysiology, drugs Embolic stroke Primary and Secondary Stroke Prevention

(Stroke. 2003;34:901.)
© 2003 American Heart Association, Inc.

Original Contributions

Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy

A Long-Term Longitudinal Study

Giuseppe Boriani, MD; Margherita Gallina, MD; Luciano Merlini, MD; Gisèle Bonne, BS; Daniela Toniolo, BS; Silvia Amati, MD; Mauro Biffi, MD; Cristian Martignani, MD; Lorenzo Frabetti, MD; Marco Bonvicini, MD; Claudio Rapezzi, MD Angelo Branzi, MD

From the Institute of Cardiology (G. Boriani, M.G., S.A., M. Biffi, C.M., L.F., M. Bonvicini, C.R., A.B.), Policlinico S. Orsola-Malpighi, University of Bologna; Center for Neuromuscular Disease (L.M.), Istituti Ortopedici Rizzoli, Bologna; and Institute of Molecular Genetics–Consiglio Nazionale delle Recerche (D.T.), Pavia, Italy, and INSERM UR523–Institute de Myologie (G. Bonne), G.H. Pitié-Salpétrière, Paris, France.

Correspondence and reprint requests to Giuseppe Boriani, MD, Institute of Cardiology, Policlinico S. Orsola-Malpighi, University of Bologna, Via Massarenti n. 9, 40138 Bologna, Italy. E-mail cardio1{at}almadns.unibo.it

Background and Purpose— Emery-Dreifuss muscular dystrophy (EDMD) is a rare inherited disorder associated with cardiac involvement. We investigated the spectrum and relevance of the cardiac manifestations of EDMD, focusing on bradyarrhythmias and tachyarrhythmias (including atrial fibrillation/flutter), embolic stroke, and heart failure.

Methods and Results— Eighteen patients (age 42.8±19.6 years) with genetically confirmed X-linked (n=10, including 3 carriers) or autosomal dominant (n=8) EDMD were followed for a period ranging from 1 to 30 years in a research center for neuromuscular diseases and in a university cardiological department. Pacemakers were required by 10 of 18 (56%) patients for bradyarrhythmia, and related complications occurred in 3 of 10 (30%) cases. Atrial fibrillation/flutter developed in 11 of 18 (61%) patients, with atrial standstill subsequently occurring in 5 of 11 (45%) cases and embolic stroke (most often disabling) in 4 of 11 (36%). Heart failure requiring transplantation occurred in 1 of 18 (6%) patients, and asymptomatic left ventricular dysfunction in a further 3 (17%). No relationship was evident between neuromuscular impairment and cardiac involvement.

Conclusions— Both X-linked and autosomal dominant EDMD patients risk not only bradyarrhythmia (requiring pacemaker implant) but also atrial fibrillation/flutter, which often anticipates atrial standstill and can cause disabling embolic stroke at a relatively young age. Antithromboembolic prophylaxis has to be recommended in EDMD patients with atrial fibrillation/flutter or atrial standstill. With careful monitoring, survival after pacemaker implant may be long. Heart failure, which seems to occur only in a minority of patients, may be severe.

Key Words: atrial fibrillation • congestive heart failure • muscular dystrophy, Emery-Dreifuss • stroke • thromboembolism

This article has been cited by other articles:

				R.P. Beynon and S.G. Ray Cardiac involvement in muscular dystrophies QJM, May 1, 2008; 101(5): 337 - 344. [Abstract] [Full Text] [PDF]

				P. G. Golzio, A. Chiribiri, and F. Gaita 'Unexpected' sudden death avoided by implantable cardioverter defibrillator in Emery Dreifuss patient Europace, December 1, 2007; 9(12): 1158 - 1160. [Abstract] [Full Text] [PDF]

				J. L. V. Broers, F. C. S. Ramaekers, G. Bonne, R. B. Yaou, and C. J. Hutchison Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev, July 1, 2006; 86(3): 967 - 1008. [Abstract] [Full Text] [PDF]

				R. Ozawa, Y. K. Hayashi, M. Ogawa, R. Kurokawa, H. Matsumoto, S. Noguchi, I. Nonaka, and I. Nishino Emerin-Lacking Mice Show Minimal Motor and Cardiac Dysfunctions with Nuclear-Associated Vacuoles Am. J. Pathol., March 1, 2006; 168(3): 907 - 917. [Abstract] [Full Text] [PDF]

				A. Garg, O. Cogulu, F. Ozkinay, H. Onay, and A. K. Agarwal A Novel Homozygous Ala529Val LMNA Mutation in Turkish Patients with Mandibuloacral Dysplasia J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5259 - 5264. [Abstract] [Full Text] [PDF]

				V Cenni, P Sabatelli, E Mattioli, S Marmiroli, C Capanni, A Ognibene, S Squarzoni, N M Maraldi, G Bonne, M Columbaro, et al. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy J. Med. Genet., March 1, 2005; 42(3): 214 - 220. [Abstract] [Full Text] [PDF]